Chris P. Sarnowski
chrispsarnowski.bsky.social
Chris P. Sarnowski
@chrispsarnowski.bsky.social
Scientist in Cell Surface Proteomics - currently changing how we treat cancer at DISCO Pharmaceuticals. Previously Eawag, ETHZ, Uni. Cambridge.

Interested in proteomics by mass spectrometry.
A huge thanks to all co-authors, especially @annaknoer.bsky.social & Tebbe de Vries for the wonderful collaboration during our doctoral studies, and the dreamy combined supervision of Alexander Leitner & Ruedi Aebersold, who together helped (finally) bring this publication to fruition!
July 14, 2025 at 6:23 PM
...a comprehensive suite of tools now exists, both for the lab and for data analysis, to enable #proteinRNA #XLMS for the masses!
July 14, 2025 at 6:23 PM
Together with...
(1) Enhanced understanding of the UV-XL chemistry (www.nature.com/articles/s41...)
(2) Novel isotope labeling chemistry using commercially available reagents (pubs.acs.org/doi/10.1021/...)
(3) A software tool to analyse such mass spectrometry data (pubs.acs.org/doi/10.1021/...)
...
www.nature.com
July 14, 2025 at 6:23 PM
In this work, we:
- Demonstrate vastly improved sensitivity/coverage compared with the initial version of the protocol
- Empirically characterise for the first time the distance represented by UV-induced protein-RNA XLs
- Compare these properties between canonical and 4-thiouracil
July 14, 2025 at 6:21 PM
Enter CLIR-MS - bringing well established cross-linking mass spectrometry principles from protein-protein interactions to protein-RNA interactions.
July 14, 2025 at 6:21 PM
We still need experimental techniques to model protein-RNA interactions. Tools like #Alphafold might be pushing new boundaries in silico, but computational predictions always require careful validation in the lab.
July 14, 2025 at 6:20 PM